Doctors at Northwell Health in New York have started a clinical trial that aims to see how famotidine, an active ingredient in Pepcid, could help improve the conditions of patients with the COVID-19.Original Article
You may also like
Gone in a Puff of Smoke? FDA’s Proposed Rule on...
FDA Appears to Be Granting Zombie Rare Pediatric...
HPM’s Larry Houck Presenting at WCF Opioid and...
Get Up To Speed on Medicare Inflation Rebates: HPM...
Into the Ashtray: FDA’s Previous Proposal to Ban...
Small Change: FDA’s Final Predetermined Change...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.